You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

VALPROIC ACID - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for valproic acid and what is the scope of freedom to operate?

Valproic acid is the generic ingredient in three branded drugs marketed by Bionpharma, Abbvie, Catalent, Eywa, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Upsher Smith Labs, Ani Pharms, Chartwell Rx, Hikma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Pharmobedient Cnsltg, and Quagen, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for valproic acid. Seventeen suppliers are listed for this compound.

Drug Prices for VALPROIC ACID

See drug prices for VALPROIC ACID

Recent Clinical Trials for VALPROIC ACID

Identify potential brand extensions & 505(b)(2) entrants

Sohag UniversityPhase 2/Phase 3
Dr Cipto Mangunkusumo General HospitalPhase 4
Wayne State UniversityPhase 4

See all VALPROIC ACID clinical trials

Medical Subject Heading (MeSH) Categories for VALPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for VALPROIC ACID

US Patents and Regulatory Information for VALPROIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scherer Rp VALPROIC ACID valproic acid CAPSULE;ORAL 070195-001 Jul 2, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bionpharma STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-003 Jul 29, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bionpharma STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-002 Jul 29, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie DEPAKENE valproic acid SYRUP;ORAL 018082-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.